Biotechnology is a science that uses or manipulates living organisms or systems to develop useful products. It has been widely used in agriculture in areas such as the genetic engineering of pest-resistant crops, or cross-breeding of animals or plants to alter their characteristics. In medicine, it has helped to develop vaccines and supplements.
Institute for Bioscience & Biotechnology Research, Columbus Center, 701 East Pratt St., Baltimore, Maryland, April 2007. Photo by Diane F. Evartt.
As part of the BioHealth Capital Region, Maryland, along with Virginia and Washington, DC, has ranked 4th in the nation in Genetic Engineering & Biotechnology News (GEN)'s annual list of Top 10 U.S. Biopharma Clusters since 2015. The rankings are based on five criteria: National Institutes of Health funding, venture capital funding, patents, lab space, and jobs. The Region's goal is to reach the "top three" by 2023.
More than 500 bioscience companies and 2,700 life science firms have chosen Maryland for their business site. Many companies are located in Montgomery County, including AstraZeneca and GlaxoSmithKline, as well as the National Institutes of Health and the U.S. Food and Drug Administration.
Maryland ranked 4th in the nation for its "core biotechnology" companies in Ernst and Young's 2006-2008 annual rankings of biotech centers.
In Maryland, the Life Sciences Advisory Board promotes science research and manufacturing. The Board also coordinates resources and seeks to support federal science facilities in the State.
Research by the University of Maryland, College Park, the University of Maryland, Baltimore, and the National Institute of Standards and Technology is used by the Institute for Bioscience & Biotechnology Research of the University System of Maryland to develop advances in science, medicine, and engineering.
BioMaryland Center, World Trade Center Baltimore, 401 East Pratt St., Baltimore, Maryland, November 2009. Photo by Diane F. Evartt.
© Copyright Maryland State Archives